Pharmacy alerts

  • Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets

    Class 4 Medicines Defect Notification: Star Pharmaceuticals Ltd, Enalapril maleate/Hydrochlorothiazide 20 mg/12.5 mg Tablets.

  • Duvyzat (givinostat): interim advice on risk mitigation measures

    Drug Safety Update: Duvyzat (givinostat) interim advice on risk mitigation measures following reports of deaths in patients while taking givinostat.

  • Tropicamide 1% Eye Drops, solution in single dose containers

    Class 3 Medicines Recall: Aspire Pharma Limited, Tropicamide 1% eye drops, solution in single dose containers 20 x 0.5ml.

  • Co-Amoxiclav powder for oral suspension 250/62.5 mg/mL

    Class 4 Medicines Defect Notification: Sandoz Limited, Co-Amoxiclav powder for oral suspension 250/62.5 mg/mL.

  • Influenza activity in England: implications for clinical practice and laboratory referral

    The UK Health Security Agency (UKHSA) has published an alert regarding influenza activity in England.

  • Update to interim clinical prioritisation guidance for blood ketone testing

    NHS England has updated the interim clinical prioritisation guidance for blood ketone testing during supply disruption.